CWP
EW icon

Clark Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Clark Wealth Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52K Sell
50
-5
-9% -$419 ﹤0.01% 318
2026
Q1 		$4.41K Hold
55
– – ﹤0.01% 354
2025
Q4 		$4.69K Hold
55
– – ﹤0.01% 342
2025
Q3 		$4.69K Hold
55
– – ﹤0.01% 342
2025
Q2 		$4.3K Buy
55
+25
+83% +$1.86K ﹤0.01% 306
2025
Q1 		$2.17K Sell
30
-87
-74% -$6.23K ﹤0.01% 361
2024
Q4 		$8.66K Buy
+117
New +$8.19K 0.01% 181

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Clark Wealth Partners's EW Position: Q2 2026 in Review

Clark Wealth Partners reduced its Edwards Lifesciences (EW) stake by 9.1% in Q2 2026, selling an estimated $419 and leaving 50 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Clark Wealth Partners first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.66K in Q4 2024. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Clark Wealth Partners held 50 shares of Edwards Lifesciences worth $4.52K as of Q2 2026.
  • Clark Wealth Partners sold 5 Edwards Lifesciences shares in Q2 2026, an estimated $419.
  • Edwards Lifesciences made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #318 holding.
  • Clark Wealth Partners first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • Clark Wealth Partners's Edwards Lifesciences position peaked at $8.66K in Q4 2024.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.